Stay updated with breaking news from 45337c10. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Royal Bank of Canada reiterated their sector perform rating on shares of Incyte (NASDAQ:INCY – Free Report) in a research note issued to investors on Monday morning, Benzinga reports. The brokerage currently has a $65.00 target price on the biopharmaceutical company’s stock. INCY has been the subject of a number of other reports. William Blair […]
Trexquant Investment LP boosted its position in Incyte Co. (NASDAQ:INCY – Free Report) by 2.9% during the 3rd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 161,645 shares of the biopharmaceutical company’s stock after acquiring an additional 4,584 shares during the period. Trexquant Investment […]
Meiji Yasuda Asset Management Co Ltd. boosted its position in Incyte Co. (NASDAQ:INCY – Free Report) by 163.2% during the 3rd quarter, Holdings Channel.com reports. The fund owned 29,113 shares of the biopharmaceutical company’s stock after buying an additional 18,050 shares during the quarter. Meiji Yasuda Asset Management Co Ltd.’s holdings in Incyte were worth […]
Meiji Yasuda Asset Management Co Ltd. raised its holdings in Incyte Co. (NASDAQ:INCY – Free Report) by 163.2% during the third quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 29,113 shares of the biopharmaceutical company’s stock after purchasing an additional 18,050 shares during […]
CI Investments Inc. trimmed its holdings in shares of Incyte Co. (NASDAQ:INCY – Free Report) by 12.4% in the third quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 3,634 shares of the biopharmaceutical company’s stock after selling 513 shares during the period. CI Investments Inc.’s […]